PULMONX CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
PULMONX CORPORATION (LUNG) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $0 as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $0.00.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $0.00.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $100.00K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $100.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 |
| 2025-12-31 | $100.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $400.00K 10-Q · filed 2025-08-01 |
| 2025-03-31 | $3.40M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $3.70M 10-K · filed 2026-03-10 |
| 2024-09-30 | $5.30M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $3.50M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $5.80M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $8.60M 10-K · filed 2025-02-25 |
| 2023-09-30 | $6.20M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $7.80M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $6.30M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $4.10M 10-K · filed 2024-02-27 |
| 2022-09-30 | $9.40M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.50M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $13.80M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $18.90M 10-K · filed 2023-03-01 |
| 2021-09-30 | $21.20M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $28.90M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $53.30M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $81.70M 10-K · filed 2022-03-01 |
| 2020-09-30 | $44.30M 10-Q · filed 2020-11-13 |
| 2019-12-31 | $7.60M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |